AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families
about
Potential Roles of Adropin in Central Nervous System: Review of Current LiteratureThe PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia.Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaGone to Pot - A Review of the Association between Cannabis and PsychosisDevelopmental origins of brain disorders: roles for dopamineDysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null miceInsulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsPHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampusPKBγ/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.Neurodevelopment in schizophrenia: the role of the wnt pathways.Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.The dystrobrevin-binding protein 1 gene: features and networksNeuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor functionDisruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients.Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunctionNeuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.Dysbindin-1 genotype effects on emotional working memoryA signaling pathway AKTing up in schizophreniaAKT1 G205T genotype influences obesity-related metabolic phenotypes and their responses to aerobic exercise training in older CaucasiansAssociation study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis.AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disordersNature and nurture in neuropsychiatric genetics: where do we stand?AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.AKT/GSK3 signaling pathway and schizophreniaEpistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implicationsBDNF-TrkB signaling and neuroprotection in schizophreniaGenetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophreniaAntipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.AKT1 Gene Polymorphisms and Obstetric Complications in the Patients with Schizophrenia.Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.
P2860
Q26742073-D74D9384-9846-42FA-8592-CD00441E6C5CQ26766054-5CD89AD8-AFA8-4E43-94F9-3CD93F80DA38Q26773403-DF4B6834-CB10-4A1E-8040-A02627FF7346Q26865311-88FB6038-5796-49E5-9807-F8E16883DB1EQ27024247-069D4405-8403-45B0-9F55-D1636FE405A7Q27324246-A16E4CC2-083C-4596-9864-DFDB4A4F94F9Q28483930-D13652DC-2263-4700-A0FF-F3DE880BD87EQ28546441-B2A41178-860E-45BC-9FCF-EC32D87BCF72Q28573668-AB388180-C0E7-4A14-A860-4E9CD3089C6CQ29994856-9D49B1E9-F1F9-4443-9B53-6EF412454801Q30360363-72D47892-F8B6-4ABC-B591-4B7B4F9AE27DQ30442237-83301D9C-D9E7-4F71-B321-CBB431B4AC5FQ30458585-1C9D4C16-6284-4651-9655-A3557FE805E7Q30458875-4F6A372D-3C82-43E6-BBC6-30D1AC48DA3FQ33570929-7C8A9F77-8573-4C54-B265-1A27B21EF138Q33592850-0730BD04-165B-4998-BC8F-B0E6A57F7C62Q33809026-A1FDC2D8-71C2-4467-A7B0-E2F1F73956B1Q33814354-2A478EFA-FE02-4AD7-9D45-134BC639A8B1Q33893744-2A8D6250-032C-4A68-8F48-34BBDEC03D5CQ34185951-CE8F24D1-606C-4B9B-9D80-D71D282A089DQ34348224-4A59224D-56D5-42D0-920D-B9B2C794C6F7Q34423863-E0BE5AE6-A57E-4F90-949E-426A6F751F26Q34508840-E8BA782A-B8D8-47DD-AA79-DCC264D96FB7Q34603149-7D513828-9ACE-4FB8-B7A4-1209C705BE2EQ34780889-D6AFBFDE-F854-4CBF-918F-76583C4648B1Q34786288-D7D09D40-221E-4B05-82E6-6073E5688271Q34901624-AC213567-932E-439E-976C-B6F1F31A9D73Q34988406-5B8BBE1D-A71F-40D5-832B-12C00C7B73B6Q35216295-5C5F4E83-3BE4-4849-AC3B-09ADFABAE1C0Q35237190-3FDAA503-AA8A-4D54-A124-3769E36274D6Q35356756-0522B70D-C027-47EA-AF1D-B44AF3C05753Q35832061-AF5DC233-E1C0-45C1-92BF-D348EC5D7C41Q36253904-E98FD42B-1B1F-4C99-BC5B-B4CC71734437Q36589545-A0437A91-6284-49F6-85A7-FF7D082C9717Q36667975-311B9D8A-9AC9-4F63-AAC2-06EB56709210Q36756253-6B9B2453-1153-4F52-A368-A619FFA8FEE0Q37139258-BA12A46A-4657-4F39-885E-EDE8C206698AQ37484073-98A3595C-2874-4A92-87A5-A8DBE2B3B228Q37633791-B1F2737F-C75F-4E49-8A29-188102FDA8C8Q37650391-7C2BF8A7-10AB-470A-BBE4-DC31B5DBCA19
P2860
AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
AKT1 is associated with schizo ...... density schizophrenia families
@ast
AKT1 is associated with schizo ...... density schizophrenia families
@en
type
label
AKT1 is associated with schizo ...... density schizophrenia families
@ast
AKT1 is associated with schizo ...... density schizophrenia families
@en
prefLabel
AKT1 is associated with schizo ...... density schizophrenia families
@ast
AKT1 is associated with schizo ...... density schizophrenia families
@en
P2093
P2860
P50
P1476
AKT1 is associated with schizo ...... density schizophrenia families
@en
P2093
Ayman Fanous
Brandon Wormley
Brien P Riley
Dawn L Thiselton
Dermot Walsh
Edwin J C G Van den Oord
Vladimir I Vladimirov
P2860
P304
P356
10.1016/J.BIOPSYCH.2007.06.005
P407
P577
2007-09-06T00:00:00Z